DELETION OF SEQUENCES UPSTREAM OF THE PROTEINASE IMPROVES THE PROTEOLYTIC PROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:64
|
作者
PARTIN, K
ZYBARTH, G
EHRLICH, L
DECROMBRUGGHE, M
WIMMER, E
CARTER, C
机构
[1] SUNY STONY BROOK, DEPT MICROBIOL, STONY BROOK, NY 11794 USA
[2] DUKE UNIV, HOWARD HUGHES MED INST, DURHAM, NC 27706 USA
关键词
ASPARTIC PROTEINASES; ZYMOGEN ACTIVATION; VIRAL MATURATION;
D O I
10.1073/pnas.88.11.4776
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus type 1 expresses structural proteins and replicative enzymes within gag and gag-pol precursor polyproteins. Specific proteolytic processing of the precursors by the viral proteinase is essential for maturation of infectious viral particles. We have studied the activity of proteinase in its immature form, as part of a gag-pol fusion protein, in an in vitro expression system. We found that deletion of p6*, the region in pol upstream of proteinase, resulted in improved processing of the precursor. A modified proteinase is released, but it functions less efficiently than wild type. Improved autoprocessing correlates with increased accessibility of the active site region in the polyprotein carrying the p6* deletion. Our results suggest that p6* is involved in the regulation of proteinase activation, perhaps as a region limiting the interaction of the active site and substrate binding domain with the remainder of the polyprotein. Release of p6* inhibition may be an activation step necessary for infectious particle maturation.
引用
收藏
页码:4776 / 4780
页数:5
相关论文
共 50 条
  • [31] CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING
    KAYE, JF
    RICHARDSON, JH
    LEVER, AML
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6588 - 6592
  • [32] MOLECULAR-BIOLOGY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HASELTINE, WA
    FASEB JOURNAL, 1991, 5 (10): : 2349 - 2360
  • [33] STIMULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY CERAMIDE
    PAPP, B
    ZHANG, DZ
    GROOPMAN, JE
    BYRN, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) : 775 - 780
  • [34] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    WEI, XP
    GHOSH, SK
    TAYLOR, ME
    JOHNSON, VA
    EMINI, EA
    DEUTSCH, P
    LIFSON, JD
    BONHOEFFER, S
    NOWAK, MA
    HAHN, BH
    SAAG, MS
    SHAW, GM
    NATURE, 1995, 373 (6510) : 117 - 122
  • [35] INFECTIOUS DECAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PLASMA
    MOUDGIL, T
    DAAR, ES
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 210 - 212
  • [36] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    SHAW, GM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S83 - S83
  • [37] QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION KINETICS
    DIMITROV, DS
    WILLEY, RL
    SATO, H
    CHANG, LJ
    BLUMENTHAL, R
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1993, 67 (04) : 2182 - 2190
  • [38] BASIC FEATURES OF THE NUCLEOCAPSID OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DARLIX, JL
    ROQUES, BP
    M S-MEDECINE SCIENCES, 1993, 9 (8-9): : 952 - 958
  • [39] MOLECULAR INSIGHTS INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PATHOGENESIS
    FEINBERG, MB
    GREENE, WC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 466 - 474
  • [40] CIRCULARIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (12) : 6942 - 6952